Literature DB >> 11217466

Analgesia of small mammals.

P A Flecknell1.   

Abstract

Small mammals receive analgesics much less frequently than more familiar species such as dogs and cats. This is probably related to the greater difficulty of recognizing pain in these species, and the uncertainty as to the most appropriate analgesic regimen to implement when the presence of pain is suspected. However, the same principles of pain assessment and analgesic use that are applied when dealing with other companion animals can be used to manage pain effectively in small mammals. All of the commonly used analgesic agents can be used safely and effectively in small mammals, although the size of many of these animals limits the use of techniques such as epidural administration or transdermal drug delivery systems. As with other species, it is important to integrate an analgesic regimen with the overall scheme of perioperative care, and to try to implement preemptive and multi-modal analgesic therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11217466     DOI: 10.1016/s1094-9194(17)30050-6

Source DB:  PubMed          Journal:  Vet Clin North Am Exot Anim Pract        ISSN: 1094-9194


  11 in total

1.  Pharmacokinetics of sustained-release analgesics in mice.

Authors:  Lon V Kendall; Ryan J Hansen; Kathryn Dorsey; Sooah Kang; Paul J Lunghofer; Daniel L Gustafson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

2.  Premedication with fentanyl-midazolam improves sevoflurane anesthesia for surgical intervention in laboratory mice.

Authors:  Miriam Lipiski; Margarete Arras; Paulin Jirkof; Nikola Cesarovic
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-05

3.  Comparative study of 2 surgical techniques for castration of guinea pigs (Cavia porcellus).

Authors:  Josée Guilmette; Isabelle Langlois; Pierre Hélie; Alexander de Oliveira El Warrak
Journal:  Can J Vet Res       Date:  2015-10       Impact factor: 1.310

4.  Respiratory rates and arterial blood-gas tensions in healthy rabbits given buprenorphine, butorphanol, midazolam, or their combinations.

Authors:  Carrie A Schroeder; Lesley J Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-03       Impact factor: 1.232

5.  Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice.

Authors:  Kirsten R Jacobsen; Natasha Fauerby; Zindy Raida; Otto Kalliokoski; Jann Hau; Flemming F Johansen; Klas Sp Abelson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Concentration-dependent Toxicity after Subcutaneous Administration of Meloxicam to C57BL/6N Mice (Mus musculus).

Authors:  Anna E Sarfaty; Caroline J Zeiss; Amy D Willis; Jorgen M Harris; Peter C Smith
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-09-20       Impact factor: 1.232

7.  Assessment of buprenorphine, carprofen, and their combination for postoperative analgesia in olive baboons (Papio anubis).

Authors:  Sarah O Allison; Lisa C Halliday; Jeffrey A French; Dmitri D Novikov; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2007-05       Impact factor: 1.232

8.  Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine.

Authors:  Matthew P Brennan; Albert J Sinusas; Tamas L Horvath; J G Collins; Martha J Harding
Journal:  Lab Anim (NY)       Date:  2009-03       Impact factor: 12.625

9.  Coronary artery ligation and intramyocardial injection in a murine model of infarction.

Authors:  Jitka A I Virag; Robert M Lust
Journal:  J Vis Exp       Date:  2011-06-07       Impact factor: 1.355

10.  Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use.

Authors:  Jorg A Auer; Allen Goodship; Steven Arnoczky; Simon Pearce; Jill Price; Lutz Claes; Brigitte von Rechenberg; Margarethe Hofmann-Amtenbrinck; Erich Schneider; R Müller-Terpitz; F Thiele; Klaus-Peter Rippe; David W Grainger
Journal:  BMC Musculoskelet Disord       Date:  2007-08-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.